RecruitingPhase 1NCT04704271
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
Sponsor
Yale University
Enrollment
100 participants
Start Date
Oct 9, 2019
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Eligibility
Min Age: 18 YearsMax Age: 55 Years
Inclusion Criteria2
- At least one lifetime exposure to cannabis
- Good physical and mental health
Exclusion Criteria2
- Cannabis naïve individuals
- Major current or recent stressors
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGInhaled THC
4 mg inhaled THC
DRUGPlacebo
Inhaled placebo (no active cannabinoids)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04704271
Related Trials
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
NCT055148991 location
Reducing Breathlessness With Dronabinol in COPD Patients
NCT064737011 location
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
NCT048108581 location
Age Differences in the Effects of Cannabis on Simulated Driving
NCT043259581 location
Sex Hormones Impact on Cannabis Response
NCT074170591 location